All Stories

  1. Proenkephalin (PENK) as a Novel Biomarker for Kidney Function
  2. Optimal Role of the Nephrologist in the Intensive Care Unit
  3. Development of a Multicenter Ward-Based AKI Prediction Model
  4. First Post-Operative Urinary Kidney Injury Biomarkers and Association with the Duration of AKI in the TRIBE-AKI Cohort
  5. Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment
  6. Common chronic conditions do not affect performance of cell cycle arrest biomarkers for risk stratification of acute kidney injury
  7. Urine Biomarkers and Perioperative Acute Kidney Injury: The Impact of Preoperative Estimated GFR
  8. Biomarkers in Acute Kidney Injury
  9. Outpatient Dialysis for Patients with AKI: A Policy Approach to Improving Care
  10. The Golden Hours of AKI: Is Oxygen Delivery the Key?
  11. Promoting Kidney Function Recovery in Patients with AKI Requiring RRT
  12. Furosemide Stress Test and Biomarkers for the Prediction of AKI Severity
  13. Tissue Inhibitor Metalloproteinase-2 (TIMP-2)*IGF-Binding Protein-7 (IGFBP7) Levels Are Associated with Adverse Long-Term Outcomes in Patients with AKI
  14. The Daily Burden of Acute Kidney Injury: A Survey of US Nephrologists on World Kidney Day
  15. Adjudication of etiology of acute kidney injury: experience from the TRIBE-AKI multi-center study
  16. Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical Adjudication
  17. Chemical Analog-to-Digital Signal Conversion Based on Robust Threshold Chemistry and Its Evaluation in the Context of Microfluidics-Based Quantitative Assays
  18. Preoperative angiotensin-converting enzyme inhibitors and angiotensin receptor blocker use and acute kidney injury in patients undergoing cardiac surgery
  19. Compliance with Antibiotic Dosing Guidelines in Critically Ill Patients Receiving Renal Replacement Therapy
  20. Urinary Cystatin C and Acute Kidney Injury After Cardiac Surgery
  21. Performance of Kidney Injury Molecule-1 and Liver Fatty Acid-Binding Protein and Combined Biomarkers of AKI after Cardiac Surgery
  22. Clinical Utility of Biomarkers of AKI in Cardiac Surgery and Critical Illness
  23. Differential Diagnosis of AKI in Clinical Practice by Functional and Damage Biomarkers: Workgroup Statements from the Tenth Acute Dialysis Quality Initiative Consensus Conference
  24. Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury
  25. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
  26. Association of Postoperative Proteinuria with AKI after Cardiac Surgery among Patients at High Risk
  27. Assessment and Diagnosis of Renal Dysfunction in the ICU
  28. Biomarkers Predict Progression of Acute Kidney Injury after Cardiac Surgery
  29. Preoperative Serum Brain Natriuretic Peptide and Risk of Acute Kidney Injury After Cardiac Surgery
  30. Presurgical Serum Cystatin C and Risk of Acute Kidney Injury After Cardiac Surgery
  31. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Pediatric Cardiac Surgery
  32. Postoperative Biomarkers Predict Acute Kidney Injury and Poor Outcomes after Adult Cardiac Surgery
  33. The Outcome of Neutrophil Gelatinase-Associated Lipocalin-Positive Subclinical Acute Kidney Injury
  34. Urinary Biomarkers in the Clinical Prognosis and Early Detection of Acute Kidney Injury